{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:54:55Z","timestamp":1773449695241,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.vaccine.2012.03.044","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T01:18:54Z","timestamp":1333070334000},"page":"3610-3617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Generation of a live rabies vaccine strain attenuated by multiple mutations and evaluation of its safety and efficacy"],"prefix":"10.1016","volume":"30","author":[{"given":"Keisuke","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsunori","family":"Masatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Okadera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.03.044_bib0005","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.03.044_bib0010","first-page":"631","article-title":"Rabies has its day","volume":"7","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"September (9644)","key":"10.1016\/j.vaccine.2012.03.044_bib0015","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(08)61462-2","article-title":"The global fight against rabies","volume":"372","author":"Burki","year":"2008","journal-title":"Lancet"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2012.03.044_bib0020","first-page":"169","article-title":"The safety and efficacy of immunizing foxes (Vulpes vulpes) using bait containing attenuated rabies virus vaccine","volume":"44","author":"Black","year":"1980","journal-title":"Can J Comp Med"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2012.03.044_bib0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7589\/0090-3558-25.4.548","article-title":"Oral vaccination of raccoons (Procyon lotor) with an attenuated (SAD-B19) rabies virus vaccine","volume":"25","author":"Rupprecht","year":"1989","journal-title":"J Wildl Dis"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2012.03.044_bib0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.7589\/0090-3558-11.3.382","article-title":"Vaccination of foxes against rabies using ingested baits","volume":"11","author":"Winkler","year":"1975","journal-title":"J Wildl Dis"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2012.03.044_bib0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7589\/0090-3558-24.3.477","article-title":"Immunization of arctic foxes (Alopex lagopus) with oral rabies vaccine","volume":"24","author":"Follmann","year":"1988","journal-title":"J Wildl Dis"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2012.03.044_bib0040","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2460\/javma.1979.175.04.376","article-title":"Vaccine-induced rabies in a pet skunk","volume":"175","author":"Debbie","year":"1979","journal-title":"J Am Vet Med Assoc"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2012.03.044_bib0045","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2460\/javma.1982.180.11.1336","article-title":"Vaccine-induced rabies in four cats","volume":"180","author":"Esh","year":"1982","journal-title":"J Am Vet Med Assoc"},{"issue":"231","key":"10.1016\/j.vaccine.2012.03.044_bib0050","first-page":"105","article-title":"Vaccine-induced rabies infection in rural dogs in Anambra State, Nigeria","volume":"57","author":"Okolo","year":"1989","journal-title":"Microbios"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2012.03.044_bib0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/vr.131.3.55","article-title":"Pathogenicity of SAD rabies vaccine given orally in chacma baboons (Papio ursinus)","volume":"131","author":"Bingham","year":"1992","journal-title":"Vet Rec"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2012.03.044_bib0060","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","article-title":"A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity","volume":"79","author":"Faber","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.03.044_bib0065","unstructured":"World Health Organization. Rabies, vaccines for parenteral use. Available from: http:\/\/www.who.int\/rabies\/vaccines\/parental_use\/en\/index.html [cited 14.02.12]."},{"issue":"August (2)","key":"10.1016\/j.vaccine.2012.03.044_bib0070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2005.04.004","article-title":"Replication strategies of rabies virus","volume":"111","author":"Finke","year":"2005","journal-title":"Virus Res"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.03.044_bib0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1073\/pnas.80.1.70","article-title":"Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus","volume":"80","author":"Dietzschold","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.03.044_bib0080","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/jvi.53.3.926-934.1985","article-title":"Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein","volume":"53","author":"Seif","year":"1985","journal-title":"J Virol"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2012.03.044_bib0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0042-6822(89)90122-0","article-title":"Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice","volume":"172","author":"Tuffereau","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2012.03.044_bib0090","first-page":"461","article-title":"Immunogenicity of the ERA G 333 rabies virus strain in foxes and raccoon dogs","volume":"131","author":"Bankovskiy","year":"2008","journal-title":"Dev Biol (Basel)"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2012.03.044_bib0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2005.03.017","article-title":"Oral vaccination of dogs with recombinant rabies virus vaccines","volume":"111","author":"Rupprecht","year":"2005","journal-title":"Virus Res"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.03.044_bib0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.virusres.2006.08.011","article-title":"Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice","volume":"123","author":"Shimizu","year":"2007","journal-title":"Virus Res"},{"issue":"8","key":"10.1016\/j.vaccine.2012.03.044_bib0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1348-0421.2003.tb03424.x","article-title":"Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system","volume":"47","author":"Ito","year":"2003","journal-title":"Microbiol Immunol"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2012.03.044_bib0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0042-6822(65)90160-1","article-title":"Growth characteristics of rabies virus in primary chick embryo cells","volume":"27","author":"Kondo","year":"1965","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2012.03.044_bib0115","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1348-0421.1994.tb01806.x","article-title":"Linear and conformation-dependent antigenic sites on the nucleoprotein of rabies virus","volume":"38","author":"Minamoto","year":"1994","journal-title":"Microbiol Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2012.03.044_bib0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1348-0421.1985.tb00884.x","article-title":"Virulence of chick embryo fibroblast-passaged flury HEP rabies virus and its revertants in mice","volume":"29","author":"Arai","year":"1985","journal-title":"Microbiol Immunol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.03.044_bib0125","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1292\/jvms.11-0151","article-title":"Amino acid substitution at position 95 in rabies virus matrix protein affects viral pathogenicity","volume":"73","author":"Ito","year":"2011","journal-title":"J Vet Med Sci"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.03.044_bib0130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.virusres.2010.09.016","article-title":"Amino acids at positions 273 and 394 in rabies virus nucleoprotein are important for both evasion of host RIG-I-mediated antiviral response and pathogenicity","volume":"155","author":"Masatani","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2012.03.044_bib0135","first-page":"1","article-title":"WHO Expert Consultation on rabies","volume":"931","year":"2005","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2012.03.044_bib0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0264-410X(94)90095-7","article-title":"Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern","volume":"12","author":"Lafay","year":"1994","journal-title":"Vaccine"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2012.03.044_bib0145","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.vaccine.2004.06.031","article-title":"In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife","volume":"23","author":"Dietzschold","year":"2004","journal-title":"Vaccine"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2012.03.044_bib0150","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1128\/JVI.02220-09","article-title":"Rabies virus nucleoprotein functions to evade activation of RIG-I-mediated antiviral response","volume":"84","author":"Masatani","year":"2010","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2012.03.044_bib0155","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1348-0421.2006.tb03875.x","article-title":"Sensitivity of rabies virus to type I interferon is determined by the phosphoprotein gene","volume":"50","author":"Shimizu","year":"2006","journal-title":"Microbiol Immunol"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2012.03.044_bib0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virusres.2008.05.011","article-title":"Amino acid at position 95 of the matrix protein is a cytopathic determinant of rabies virus","volume":"137","author":"Mita","year":"2008","journal-title":"Virus Res"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2012.03.044_bib0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/jvi.56.1.12-18.1985","article-title":"Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro","volume":"56","author":"Dietzschold","year":"1985","journal-title":"J Virol"},{"issue":"November (50)","key":"10.1016\/j.vaccine.2012.03.044_bib0170","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1016\/j.vaccine.2008.08.069","article-title":"Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene","volume":"26","author":"Cenna","year":"2008","journal-title":"Vaccine"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2012.03.044_bib0175","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/JVI.01552-10","article-title":"Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination","volume":"85","author":"Wen","year":"2011","journal-title":"J Virol"},{"issue":"August (31)","key":"10.1016\/j.vaccine.2012.03.044_bib0180","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/S0264-410X(01)00186-4","article-title":"Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination","volume":"19","author":"Orciari","year":"2001","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.03.044_bib0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-5699(92)90158-4","article-title":"The role of nasopharyngeal lymphoid tissue","volume":"13","author":"Kuper","year":"1992","journal-title":"Immunol Today"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12004343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12004343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:18:47Z","timestamp":1759400327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12004343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":37,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0264410X12004343"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of a live rabies vaccine strain attenuated by multiple mutations and evaluation of its safety and efficacy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}